Lupus-like syndrome induced by anti-tumor necrosis factor treatment/Anti-TNF tedaviyle induklenen lupus benzeri sendrom

Anti-tumor necrosis factor (TNF) agents have been successfully used in the treatment of inflammatory rheumatic diseases for more than 10 years. Although it is rare disease, a lupus-like syndrome may develop and life-threatening visceral involvement may be observed during treatment with anti-TNF drug...

Full description

Saved in:
Bibliographic Details
Published in:Türkiye fiziksel tip ve rehabilitasyon dergisi 2015-12, p.371
Main Authors: Comertoglu, Ismail, Kurt, Memet, Yalcin, Ayse Peyman
Format: Article
Language:Turkish
Subjects:
Care and treatment
Complications and side effects
Diagnosis
Dosage and administration
Infliximab
Lupus
Risk factors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anti-tumor necrosis factor (TNF) agents have been successfully used in the treatment of inflammatory rheumatic diseases for more than 10 years. Although it is rare disease, a lupus-like syndrome may develop and life-threatening visceral involvement may be observed during treatment with anti-TNF drugs. Herein, we present a patient with ankylosing spondylitis who developed a lupus-like syndrome while undergoing treatment with infliximab.
ISSN:1302-0234
DOI:10.5152/tftrd.2015.30111